Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Influenza

  Free Subscription


11.05.2026

1 Antimicrob Agents Chemother
1 Antiviral Res
1 Cell
1 Epidemiol Infect
3 J Gen Virol
2 J Infect
1 J Virol
2 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 PLoS Biol
1 PLoS Comput Biol
2 PLoS Med
9 PLoS One
1 Proc Natl Acad Sci U S A
12 Vaccine
4 Virology
4 Virus Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. SULEA T, Stuible M, Moreno M, Pelletier A, et al
    Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.
    Antimicrob Agents Chemother. 2026;70:e0002426.
    PubMed         Abstract available


    Antiviral Res

  2. CHIBA S, Kiso M, Yamayoshi S, Uraki R, et al
    Niclosamide inhibits the replication of highly pathogenic avian influenza A (H5Nx) viruses and antiviral-resistant mutants.
    Antiviral Res. 2026;251:106421.
    PubMed         Abstract available


    Cell

  3. HAVENS JL, Kosakovsky Pond SL, Zehr JD, Pekar JE, et al
    Dynamics of natural selection preceding human viral epidemics and pandemics.
    Cell. 2026;189:2762-2775.
    PubMed         Abstract available


    Epidemiol Infect

  4. MORTON LC, Forshey BM, Klinkhammer KE, Romaner A, et al
    Local genomic epidemiology investigations of SARS-CoV-2 during the early pandemic response: A global systematic review.
    Epidemiol Infect. 2026;154:e56.
    PubMed         Abstract available


    J Gen Virol

  5. SANTOS IA, Grosche VR, Oliveira LDS, Guarda PHS, et al
    Copper(II) benzyloxychalcone analogues as new potential metallodrugs against SARS-CoV-2 replication.
    J Gen Virol. 2026;107:002245.
    PubMed         Abstract available

  6. ISLAM MT, Pillatzki A, Webb B, Ramamoorthy S, et al
    Infectivity of recombinant Torque teno sus virus 1 in pigs coinfected with swine influenza virus.
    J Gen Virol. 2026;107:002264.
    PubMed         Abstract available

  7. SCHAFERS J, Warren CJ, Yang J, Zhang J, et al
    Stability of influenza viruses in the milk of cows and sheep.
    J Gen Virol. 2026;107:002257.
    PubMed         Abstract available


    J Infect

  8. BEHARIER O, Guedalia J, Sehtman-Shachar DR, Kerem L, et al
    Maternal SARS-CoV-2 Infection and Early Child Growth and Development: A Nationwide Cohort Study.
    J Infect. 2026 Apr 17:106749. doi: 10.1016/j.jinf.2026.106749.
    PubMed         Abstract available

  9. PEREZ-MAZZALI M, Perez-Cozar F, Cal-Sabater P, Rybakowska P, et al
    Persistent T cell phenotypic alterations and early innate immune dysregulation as potential biomarkers of Long COVID.
    J Infect. 2026 Mar 17:106731. doi: 10.1016/j.jinf.2026.106731.
    PubMed         Abstract available


    J Virol

  10. ZHANG L, Hoffmann M, Pohlmann S
    Lock out: targeting TMPRSS2 to block influenza and coronaviruses.
    J Virol. 2026 May 4:e0080725. doi: 10.1128/jvi.00807.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  11. KIBIGER L, Oltean HN, Leitz L, Krause E, et al
    Fatal Human Case of Highly Pathogenic Avian Influenza A(H5N5) in a Backyard Flock Owner - Washington, November 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:221-225.
    PubMed         Abstract available

  12. VAUGHAN A, Joyce A, Traub E, Jae M, et al
    Serologic Evidence of Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Veterinary Professional Exposed to an Infected Domestic Cat - Los Angeles County, California, December 2024-January 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:215-220.
    PubMed         Abstract available


    N Engl J Med

  13. LITE TL, Goya S, Davis ML, Morris AE, et al
    Human Infection with Highly Pathogenic Avian Influenza A(H5N5) Virus.
    N Engl J Med. 2026 May 7. doi: 10.1056/NEJMc2518178.
    PubMed        

  14. LEROUX-ROELS I, Huang G, Ferguson M, Kohli A, et al
    Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults.
    N Engl J Med. 2026;394:1803-1813.
    PubMed         Abstract available


    PLoS Biol

  15. CAMPBELL AJ, Shephard M, Paulos AP, Pauly MD, et al
    Surveillance on California dairy farms reveals multiple possible sources of H5N1 influenza virus transmission.
    PLoS Biol. 2026;24:e3003761.
    PubMed         Abstract available


    PLoS Comput Biol

  16. MCTIERNAN J, Zhang Y, Li S, Kuhlman TE, et al
    Clustering of SARS-CoV-2 membrane proteins in lipid bilayer membranes.
    PLoS Comput Biol. 2026;22:e1014229.
    PubMed         Abstract available


    PLoS Med

  17. O'HAGAN A, Pechey R, Forde H, Bandy L, et al
    Adherence to voluntary UK sugar, salt, and calorie reduction targets in the highest-grossing restaurant chains: A cross-sectional study.
    PLoS Med. 2026;23:e1004681.
    PubMed         Abstract available

  18. KRUK ME, Kapoor NR, Arsenault C, Carai S, et al
    Health system use and experience among people with poor mental health: A cross-sectional analysis of the People's Voice Survey in 18 countries.
    PLoS Med. 2026;23:e1004745.
    PubMed         Abstract available


    PLoS One

  19. DO NASCIMENTO AI, Dos Santos Conrado D, Mareto LK, de Azevedo MV, et al
    Age and vaccine information sources drive vaccine hesitancy: A household survey in Central-Western Brazil.
    PLoS One. 2026;21:e0348412.
    PubMed         Abstract available

  20. SIEBELS K, Ogden NH, Turgeon P, Lapeyre J, et al
    The impact of non-pharmaceutical interventions on the socio-economic and demographic determinants of COVID-19 incidence: A spatial analysis of the pandemic in Toronto, Canada.
    PLoS One. 2026;21:e0347649.
    PubMed         Abstract available

  21. CHU L, Hollar TL, Klimas N, Bertolli J, et al
    Facilitators of and barriers to participation in Long COVID research: A qualitative analysis.
    PLoS One. 2026;21:e0346007.
    PubMed         Abstract available

  22. WEATHERALD J, Wen C, Sharpe H, Leung WM, et al
    Impact of the COVID-19 pandemic on sex-related disparities in cystic fibrosis healthcare utilization and outcomes: A population study.
    PLoS One. 2026;21:e0345009.
    PubMed         Abstract available

  23. BIR C, Jung J, Widmar NO
    Understanding why people value working from home or hybrid workplace flexibility a study of preferences during the COVID-19 pandemic.
    PLoS One. 2026;21:e0348206.
    PubMed         Abstract available

  24. KABATA Y, Terauchi R, Nakano T
    Nationwide trends and regional variation in intravitreal injections and anti-VEGF agent use in Japan from 2017 to 2022: An analysis of the NDB Open Data.
    PLoS One. 2026;21:e0348087.
    PubMed         Abstract available

  25. PARK JH, Lee MT, Jung SY, Choi ST, et al
    Association between coronavirus disease 2019 and new-onset autoimmune diseases during the early phase of the pandemic.
    PLoS One. 2026;21:e0347872.
    PubMed         Abstract available

  26. TORREJON-GUIRADO MC, Baena-Jimenez MA, Lima-Serrano M
    Association between cannabis use and result of COVID-19 testing among scholarised adolescents in Andalusia: A cross-sectional study.
    PLoS One. 2026;21:e0347098.
    PubMed         Abstract available

  27. COSKUNER AKTAS S
    Work-family conflict in times of crisis: The moderating roles of self-efficacy and time-based spousal support during pandemic-induced remote work.
    PLoS One. 2026;21:e0348368.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  28. WAN Z, Yu L, Yang Z, Luo S, et al
    Stag2-mediated chromatin dynamics regulates antibody class switch recombination.
    Proc Natl Acad Sci U S A. 2026;123:e2536391123.
    PubMed         Abstract available


    Vaccine

  29. BEOGO I, Muray M, Kibret TC, Xu Y, et al
    Between racism and rumors: understanding vaccine mistrust among older racially diverse adults in Canada.
    Vaccine. 2026;82:128611.
    PubMed         Abstract available

  30. CONNER TL, Goguet E, Haines-Hull H, Segard A, et al
    mRNA COVID-19 vaccination induces minimal IgA in saliva in the absence of prior clinical or subclinical infection.
    Vaccine. 2026;82:128612.
    PubMed         Abstract available

  31. SARNAIK AY, Khan ZU, Rajeswaran T, Majoe A, et al
    The role of misinformation in COVID-19 vaccine hesitancy in low- & middle-income countries.
    Vaccine. 2026;82:128595.
    PubMed         Abstract available

  32. PAUL KK, Torres M, Shih STF, Gray RT, et al
    Estimating the cost-effectiveness of respiratory syncytial virus (RSV) vaccination program for older Australian adults.
    Vaccine. 2026;82:128591.
    PubMed         Abstract available

  33. GULATI RR, Yaqub F, Goodman AL
    Enhancing uptake of respiratory vaccinations in asthma and chronic obstructive pulmonary disease (COPD) patients: a systematic review.
    Vaccine. 2026;81:128560.
    PubMed         Abstract available

  34. WU JD, Meng H, Guo XL, Liu L, et al
    The immune response of the mRNA vaccine CS-2034 as a heterologous booster before and after breakthrough infection: A follow-up study.
    Vaccine. 2026;81:128575.
    PubMed         Abstract available

  35. HIRAKAWA T, Yamada G, Tokiya M, Furukawa T, et al
    Impact of pre-vaccination active vitamin D levels on COVID-19 mRNA vaccine-induced immunity in a Japanese cohort.
    Vaccine. 2026;81:128576.
    PubMed         Abstract available

  36. KONLAN M, Bhandari R, Owusu SA, Kubio C, et al
    The effect of the COVID-19 pandemic on routine childhood immunization coverage and dropout: A community-based cross-sectional study in the Tamale Metropolis, Ghana.
    Vaccine. 2026;81:128584.
    PubMed         Abstract available

  37. REYNALDI A, Lee WS, Selva KJ, Audsley J, et al
    Immune responses associated with protection from SARS-CoV-2 infection.
    Vaccine. 2026;81:128579.
    PubMed         Abstract available

  38. HIGGINS RA, Mazarakis N, Sun C, Toh ZQ, et al
    Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.
    Vaccine. 2026;81:128574.
    PubMed         Abstract available

  39. GASHEMA P, Iradukunda PG, Rudacogora JC, Siddig EE, et al
    Unlocking Africa's vaccine Independence: The critical role of technology transfer and intellectual property.
    Vaccine. 2026;81:128573.
    PubMed         Abstract available

  40. HAVERKATE MR, van de Kassteele J, van den Hof S, Sanders JG, et al
    The effect of pre-booked appointments on COVID-19 vaccine uptake among previously vaccinated older adults during the 2023 autumn campaign in the Netherlands: a regression discontinuity analysis.
    Vaccine. 2026;81:128565.
    PubMed         Abstract available


    Virology

  41. ZHU M, Wang R, Li X, Zhou H, et al
    Canine influenza virus at the human-animal interface: origins, adaptive evolution, and implications for public health.
    Virology. 2026;621:110943.
    PubMed         Abstract available

  42. LIU C, Yuan X
    Respiratory viruses as key drivers of pulmonary fibrosis: integrated pathways from barrier injury to immune-fibrotic crosstalk.
    Virology. 2026;620:110913.
    PubMed         Abstract available

  43. SULLIVAN-HILL B, Shahrudin S, Ashley CL, Shields NJ, et al
    SARS-CoV-2 variant-specific enhancement of dendritic heparan sulfate mimetic antiviral activities.
    Virology. 2026;620:110915.
    PubMed         Abstract available

  44. KIMURA R, Hayashi Y, Fujimoto-Sato Y, Ishii H, et al
    Decoding viral evolution through integrative bioinformatics: From genomes to global health.
    Virology. 2026;620:110920.
    PubMed         Abstract available


    Virus Res

  45. WANG X, Guo J, Liu J, Jiang J, et al
    Shared genetic structure between COVID-19 and migraine: insights from large-scale genome-wide cross-trait analysis.
    Virus Res. 2026;367:199708.
    PubMed         Abstract available

  46. NAGHIBOSADAT M, Hahn E, Molinaro S, Babuadze G, et al
    Comparison of SARS-CoV-2 variant pathogenicity in a long-COVID Syrian hamster model.
    Virus Res. 2026;367:199711.
    PubMed         Abstract available

  47. SITHOLE MN, Khan MR, Mohammed HA, Khan RA, et al
    A Systematic Review on Vaccine Developmental Approaches: Evaluating Efficacy, and Addressing Challenges of Infectious Diseases in the Post-COVID-19 Era.
    Virus Res. 2026 Apr 1:199720. doi: 10.1016/j.virusres.2026.199720.
    PubMed         Abstract available

  48. LIU Y, Wang C, Yan D, Zhang Y, et al
    Prognostic prediction in COVID-19 patients: a comprehensive analysis of gut microbiota and hematological biomarkers.
    Virus Res. 2026;367:199729.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum